AU Patent

AU2014271290C1 — Androgen receptor modulators and uses thereof

Assigned to Aragon Pharmaceuticals Inc · Expires 2016-10-27 · 10y expired

What this patent protects

Androgen Receptor Modulators and Uses Thereof Abstract Described herein are compounds that are androgen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such androgen recep…

USPTO Abstract

Androgen Receptor Modulators and Uses Thereof Abstract Described herein are compounds that are androgen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such androgen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon androgen receptors.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014271290C1
Jurisdiction
AU
Classification
—
Expires
2016-10-27
Drug substance claim
No
Drug product claim
No
Assignee
Aragon Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.